Albemarle Stock Forecast, Price & News

Albemarle's stock was trading at $70.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ALB stock has increased by 14.8% and is now trading at $80.42.
View which stocks have been most impacted by COVID-19.

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 6 sell ratings, 13 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Albemarle.

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Albemarle.

Albemarle will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Albemarle Co. (NYSE:ALB) announced its quarterly earnings results on Wednesday, August, 5th. The specialty chemicals company reported $0.86 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.72 by $0.14. Albemarle had a net margin of 12.99% and a return on equity of 13.33%.
View Albemarle's earnings history.

Albemarle declared a quarterly dividend on Tuesday, July 14th. Stockholders of record on Friday, September 18th will be paid a dividend of $0.385 per share on Thursday, October 1st. This represents a $1.54 annualized dividend and a dividend yield of 1.91%. The ex-dividend date of this dividend is Thursday, September 17th.
View Albemarle's dividend history.

Albemarle issued an update on its third quarter 2020 After-Hours earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $700-775 million, compared to the consensus revenue estimate of $717.55 million.

25 analysts have issued 12 month target prices for Albemarle's shares. Their forecasts range from $40.00 to $116.00. On average, they expect Albemarle's share price to reach $78.18 in the next year. This suggests that the stock has a possible downside of 2.8%.
View analysts' price targets for Albemarle.

Albemarle saw a decrease in short interest during the month of August. As of August 14th, there was short interest totaling 10,530,000 shares, a decrease of 13.6% from the July 30th total of 12,190,000 shares. Based on an average daily volume of 1,180,000 shares, the days-to-cover ratio is currently 8.9 days. Approximately 10.0% of the shares of the stock are sold short.
View Albemarle's Short Interest.

Some companies that are related to Albemarle include Sherwin-Williams (SHW), Ecolab (ECL), Valaris (VAL), Celanese (CE), International Flavors & Fragrances (IFF), RPM International (RPM), Ashland Global (ASH), NewMarket (NEU), Quaker Chemical (KWR), Balchem (BCPC), W. R. Grace & Co (GRA), Stepan (SCL), HB Fuller (FUL), Sensient Technologies (SXT) and PolyOne (POL).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), NVIDIA (NVDA), Alibaba Group (BABA) and Rogers Communications (RCI).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.89%), FMR LLC (2.56%), Bank of New York Mellon Corp (2.42%), ProShare Advisors LLC (1.23%), KAMES CAPITAL plc (1.00%) and US Bancorp DE (0.88%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier.
View institutional ownership trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Grantham Mayo Van Otterloo & Co. LLC, Eastern Bank, Cibc World Markets Corp, Robecosam AG, Federated Hermes Inc., Toronto Dominion Bank, and Advisor Group Holdings Inc.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, and Scott Tozier.
View insider buying and selling activity for Albemarle.

ALB stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Avalon Investment & Advisory, US Bancorp DE, Marathon Asset Management LLP, Ensign Peak Advisors Inc, Zweig DiMenna Associates LLC, Perseverance Asset Management International, and Hardman Johnston Global Advisors LLC. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris.
View insider buying and selling activity for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $80.42.

Albemarle has a market capitalization of $8.55 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

The official website for Albemarle is www.albemarle.com.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]